| Pharmaceutical active ingredients: |
| Physostigmine |
| Available forms, composition and doses of Esromiotin: |
| N / A |
| Esromiotin medical category: |
| Human:Parasympathomemetic (cholinergic) agents |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| S01EB05 - PhysostigmineV03AB19 - Physostigmine |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| Unidentified Pharmaceutical Company |
| Trade name |
Active ingredients |
Pharmaceutical company |
|
Esparinal | Promazine | Unidentified Pharmaceutical Company |
| Esphygmogenina | Epinephrine | Unidentified Pharmaceutical Company |
| Espiritin | Lactic Acid | Unidentified Pharmaceutical Company |
| Espril | Nialamide | Unidentified Pharmaceutical Company |
| Esracaine | Lidocaine | Unidentified Pharmaceutical Company |
| Estafilol | Sulfathiazole | Unidentified Pharmaceutical Company |
| Estasil | Meprobamate | Unidentified Pharmaceutical Company |
| Estazol | Stanozolol | Unidentified Pharmaceutical Company |
| Esteed | Ethinyl Estradiol | Unidentified Pharmaceutical Company |
| Estergel | Isopropyl Myristate | Unidentified Pharmaceutical Company |